SCHEMBL8167143

SCHEMBL8167143

CN(C)CCNC(=O)CN1CCc2cc(-c3ccccc3)ccc2C1=O

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 14/20 0.52
LMNA P02545 1/20 0.50
KCNH2 Q12809 10/20 0.48
HTR1A P08908 3/20 0.48
DRD2 P14416 1/20 0.44
DRD4 P21917 1/20 0.44
DRD3 P35462 1/20 0.44
MEN1 O00255 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
ITGB3 P05106 1/20 0.43
ITGA2B P08514 1/20 0.43
SLC6A4 P31645 2/20 0.43
HRH1 P35367 2/20 0.43
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.41
THRB P10828 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8160681 0.86 HRH3 (0.52) HRH3KCNH2HTR1ADRD2DRD4
SCHEMBL505140 0.85 GRM5 (0.59) LMNAMEN1RAB9AKMT2AITGB3
SCHEMBL10242788 0.83 HRH3 (0.68) HRH3KCNH2HTR1ASLC6A4HRH1
SCHEMBL8154132 0.81 HRH3 (0.54) HRH3KCNH2HTR1ADRD2DRD4
SCHEMBL8161014 0.79 HRH3 (0.58) HRH3KCNH2HTR1ADRD2DRD4
SCHEMBL8160622 0.78 HRH3 (0.62) HRH3KCNH2HTR1ADRD2DRD4
SCHEMBL10246397 0.75 HRH3 (0.60) HRH3KCNH2HTR1ADRD2DRD4
SCHEMBL10242687 0.74 HRH3 (0.55) HRH3KCNH2HTR1ADRD2DRD4
SCHEMBL8159331 0.73 HRH3 (0.73) HRH3KCNH2DRD2DRD4DRD3
SCHEMBL8163729 0.72 HRH3 (0.58) HRH3KCNH2HTR1AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120028955-A1 BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME VANDERBILT UNIVERSITY 2012-02-02 US disclosed
US-20120028956-A1 BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME VANDERBILT UNIVERSITY 2012-02-02 US disclosed
US-8034806-B2 Bicyclic mGluR5 positive allosteric modulators and methods of making and using same VANDERBILT UNIVERSITY (US) 2011-10-11 US disclosed
US-20090270362-A1 BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME VANDERBILT UNIVERSITY 2009-10-29 US disclosed
WO-2008151184-A1 BENZAMIDE MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME VANDERBILT UNIVERSITY (US) 2008-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028955-A1 BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME GRM5, GRIK5, GRM1 HRH3 838/4885LMNA 4774/4885KCNH2 903/4885
US-20120028956-A1 BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME GRM5, GRIK5, GRM1 HRH3 838/4885LMNA 4774/4885KCNH2 903/4885
US-20090270362-A1 BICYCLIC MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME GRM5, GRIK5, GRM1 HRH3 838/4885LMNA 4774/4885KCNH2 903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.